OSLO, NORWAY – 20 May 2022: Genetic Analysis AS (“GA” or “the Company”) announce that a member of the management has bought GEAN-shares.
Ronny Hermansen, CEO in Genetic Analysis AS, has through the fully owned company InVitroDia AS today bought 23.000 GEAN-shares at an average price of 3,68 NOK per share. The shares were acquired on the Spotlight Stock Market. Following the transaction, Ronny Hermansen including controlled company owns 192.040 shares and 49,998 tradable subscription rights GEAN T01/T02.
Read the press release in English: